Contact Us
UBC Insights

Insights from
UBC's Expert Voices

Featured Updates

Featured Image
Blog
December 16, 2025 18 min read

Navigating the AI Landscape: Choosing the Right Model for Your PV Needs
AI is no longer just a buzzword—it’s a practical tool shaping how we work every day. Learn how UBC leverages AI models to streamline tasks, enhance decision-making, and maintain compliance.
Featured Image
Blog
December 15, 2025 2 min read

Redefining Real-World Data: How Datavant Scales Medical Record Retrieval for Complete, Connected Insights
Modern medical record retrieval is transforming real-world evidence. Datavant’s approach combines nationwide reach, deep data connectivity, and high record yields to deliver comprehensive, research-ready datasets.
Featured Image
Blog
December 3, 2025 7 min read

2025 NORD Rare Disease Summit: Advancing Evidence and Partnerships for the Rare Community
UBC attended the 2025 NORD Rare Diseases & Orphan Products Breakthrough Summit, where patient voices, scientific innovation, and regulatory expertise converged to shape the future of rare-disease research. Learn what inspired us and how we’re advancing real-world evidence, patient partnerships, and innovative trial designs to accelerate progress for the rare-disease community.
Julie Shutt
Associate Director, Patient Engagement

Posts by Date

Featured Image
Blog
December 16, 2025 18 min read

Navigating the AI Landscape: Choosing the Right Model for Your PV Needs
AI is no longer just a buzzword—it’s a practical tool shaping how we work every day. Learn how UBC leverages AI models to streamline tasks, enhance decision-making, and maintain compliance.
Featured Image
Blog
December 15, 2025 2 min read

Redefining Real-World Data: How Datavant Scales Medical Record Retrieval for Complete, Connected Insights
Modern medical record retrieval is transforming real-world evidence. Datavant’s approach combines nationwide reach, deep data connectivity, and high record yields to deliver comprehensive, research-ready datasets.
Featured Image
Blog
December 3, 2025 7 min read

2025 NORD Rare Disease Summit: Advancing Evidence and Partnerships for the Rare Community
UBC attended the 2025 NORD Rare Diseases & Orphan Products Breakthrough Summit, where patient voices, scientific innovation, and regulatory expertise converged to shape the future of rare-disease research. Learn what inspired us and how we’re advancing real-world evidence, patient partnerships, and innovative trial designs to accelerate progress for the rare-disease community.
Julie Shutt
Associate Director, Patient Engagement
cell and gene, dna
Blog
November 21, 2025 5 min read

High-Touch, High-Impact: Optimizing Patient Support in Cell & Gene Therapy
As cell and gene therapies reshape treatment paradigms, patient support programs must evolve to meet new challenges. Discover how strategic alignment, payer advocacy, and innovative solutions can optimize the patient journey.
Dana Edwards
Vice President, Patient Access & Strategic Engagement
lightbulb in center
Blog
November 19, 2025 6 min read

Registry feasibility assessments for post-authorization safety studies (PASS): Learnings and Challenges
UBC recently completed a multi-country feasibility assessment to identify disease registries capable of supporting a PASS for a novel therapy targeting a hereditary muscular disorder. The study evaluated registry data elements, quality, and governance to ensure fit-for-purpose real-world data (RWD) for generating reliable RWE.
Featured Image
Blog
November 18, 2025 9 min read

Making the most of real-time pharmacovigilance oversight: Applying operational data analytics across diverse use cases
Learn how companies are making the most of their oversight capabilities by leveraging real-time data to improve the health of their pharmacovigilance program.
Featured Image
Blog
November 13, 2025 20 min read

Putting a Seatbelt on AI: How Risk-Based Integration is Transforming Drug Safety
AI is revolutionizing drug safety, but without proper guardrails, it can introduce new risks. Learn how risk-based integration strategies are helping life sciences companies harness AI’s power while maintaining trust, transparency, and compliance.
Featured Image
Blog
November 5, 2025 12 min read

Operational Data On Demand: Overcoming Barriers to Effective Pharmacovigilance Oversight
Platforms designed specifically for the collection and communication of operational pharmacovigilance data are breaking down long-standing barriers to real-time PV oversight.
Featured Image
Blog
October 30, 2025 6 min read

Drug Repurposing in Rare Diseases: The Impact of Natural History Studies
Drug repurposing is transforming the landscape of rare disease treatment by leveraging existing medications for new uses. With significantly lower development costs and faster timelines, this approach is gaining traction—especially when supported by natural history studies that provide deep insights into disease progression and real-world treatment patterns.
Samuel Igweokpala
Associate Epidemiologist
1 2 3 … 18

Press Inquires
UBC logo white

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

  • Leverage automation to move fast
  • Always give customers a human to chat to
  • Automate customer support and close leads faster
Return to Homepage
Connect with Us on LinkedIn
UBC logo white

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.